Covid-19: A puzzle with many missing pieces

The BMJ

Volumn 368, Issue , 2020, Pages

  Vetter, Pauline ^a   Eckerle, Isabella ^a,b   Kaiser, Laurent ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ASCORBIC ACID; CHINESE DRUG; HYDROXYCHLOROQUINE; INTERFERON; MONOCLONAL ANTIBODY; NUCLEOTIDE DERIVATIVE; OSELTAMIVIR; PROTEINASE INHIBITOR; REMEDESEVIR; UMIFENOVIR; UNCLASSIFIED DRUG; VIRUS VACCINE;

CASE FATALITY RATE; CHINA; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DISEASE SEVERITY; EBOLA HEMORRHAGIC FEVER; EDITORIAL; ENVIRONMENTAL FACTOR; EPIDEMIC; HEREDITY; HUMAN; INFECTION PREVENTION; LABORATORY TEST; LOW RISK PATIENT; MIDDLE EAST RESPIRATORY SYNDROME; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIODIAGNOSIS; SARS CORONAVIRUS; SEASONAL INFLUENZA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; UPPER RESPIRATORY TRACT INFECTION; VIRUS PATHOGENESIS; VIRUS PNEUMONIA; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 85079756319     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.m627     Document Type: Editorial

References (12)

1. Coronavirus disease. 2019 (COVID-19): situation report-26, 15 February 2020. Geneva: World Health Organization, 2020 (https://www.who.int/docs/default-source/coronaviruse/ situation-reports/20200215-sitrep-26-covid-19.pdf?sfvrsn=a4cc6787-2).
2. Huang C, Wang Y, Li X, etal . Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet, 202010.1016/S0140-6736(20)30183-5.
3. Xu X-W, Wu X-X, Jiang X-G, etal . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;368:m606.
4. Chan JF, Yuan S, Kok KH, etal . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514-23. 10.1016/S0140-6736(20)30154-9 31986261
5. Pongpirul WA, Pongpirul K, Ratnarathon AC, Prasithsirikul W. Journey of a Thai Taxi Driver and Novel Coronavirus. N Engl J Med 2020. 10.1056/NEJMc2001621 32050060
6. To KK, Tsang OT, Chik-Yan Yip C, etal . Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020;ciaa149. 10.1093/cid/ciaa149 32047895
7. Zhu N, Zhang D, Wang W, etal. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020. 10.1056/NEJMoa2001017 31978945
8. Zhang H, Kang ZJ, Gong HY, etal . The digestive system is a potential route of 2019 nCoV infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv 927806 [Preprint]. 2020. 10.1101/2020.01.30
9. Wang M, Cao R, Zhang L, etal . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020. 10.1038/s41422-020-0282-0 32020029
10. Mulangu S, Dodd LE, Davey RTJr, etal. PALM Writing GroupPALM Consortium Study Team. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N Engl J Med 2019;381:2293-303. 10.1056/NEJMoa1910993 31774950
11. Alansari K, Toaimah FH, Almatar DH, El Tatawy LA, Davidson BL, Qusad MIM. Monoclonal Antibody Treatment of RSV Bronchiolitis in Young Infants: A Randomized Trial. Pediatrics 2019;143:pii. 10.1542/peds.2018-2308 30760509
12. Beigel JH. Polyclonal and monoclonal antibodies for the treatment of influenza. Curr Opin Infect Dis 2018;31:527-34. 10.1097/QCO.0000000000000499 30299360